We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSW icon
2526
OneSpaWorld
OSW
$2.66B
$541K ﹤0.01%
55,819
-11,748
-17% -$128K
SEER icon
2527
Seer Inc
SEER
$120M
$540K ﹤0.01%
16,483
+2,763
+20% +$109K
GERN icon
2528
Geron
GERN
$949M
$539K ﹤0.01%
382,300
-44,667
-10% -$65K
STFC
2529
DELISTED
State Auto Financial Corp
STFC
$539K ﹤0.01%
31,493
-2,930
-9% -$54.8K
BFST icon
2530
Business First Bancshares
BFST
$1.03B
$537K ﹤0.01%
23,410
-3,039
-11% -$72K
HRMY icon
2531
Harmony Biosciences
HRMY
$2.24B
$536K ﹤0.01%
+19,000
New +$570K
VERI icon
2532
Veritone
VERI
$122M
$536K ﹤0.01%
27,198
-2,205
-7% -$47.9K
VAPO
2533
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$535K ﹤0.01%
2,832
+11
+0.4% +$1.88K
UFPT icon
2534
UFP Technologies
UFPT
$2.43B
$534K ﹤0.01%
9,308
-1,608
-15% -$87.3K
GATO
2535
DELISTED
Gatos Silver, Inc.
GATO
$532K ﹤0.01%
30,445
+7,985
+36% +$113K
ATNX
2536
DELISTED
Athenex, Inc. Common Stock
ATNX
$532K ﹤0.01%
5,762
+806
+16% +$73.3K
PRAX icon
2537
Praxis Precision Medicines
PRAX
$10.1B
$531K ﹤0.01%
1,938
+1,232
+175% +$441K
KLRS
2538
Kalaris Therapeutics
KLRS
$96.8M
$531K ﹤0.01%
1,169
-86
-7% -$44.4K
DV icon
2539
DoubleVerify
DV
$2.03B
$529K ﹤0.01%
+12,494
New +$445K
IIIV icon
2540
i3 Verticals
IIIV
$342M
$529K ﹤0.01%
17,513
+253
+1% +$8.02K
RBNC
2541
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$529K ﹤0.01%
19,084
-2,117
-10% -$60.8K
AHT
2542
Ashford Hospitality Trust
AHT
$21M
$528K ﹤0.01%
+1,158
New +$420K
MCFT icon
2543
MasterCraft Boat Holdings
MCFT
$590M
$526K ﹤0.01%
20,006
-1,575
-7% -$44K
TLS icon
2544
Telos
TLS
$358M
$525K ﹤0.01%
15,445
+1,112
+8% +$37.5K
EMWP
2545
DELISTED
Eros Media World PLC
EMWP
$525K ﹤0.01%
17,167
+6,380
+59% +$174K
ASPN icon
2546
Aspen Aerogels
ASPN
$518M
$524K ﹤0.01%
17,521
-7,655
-30% -$156K
IWR icon
2547
iShares Russell Mid-Cap ETF
IWR
$57.4B
$524K ﹤0.01%
+6,608
New +$513K
RM icon
2548
Regional Management Corp
RM
$303M
$523K ﹤0.01%
11,238
-3,019
-21% -$131K
TCS
2549
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$523K ﹤0.01%
2,675
-55
-2% -$11.4K
VERU icon
2550
Veru
VERU
$37.4M
$522K ﹤0.01%
6,465
+1,502
+30% +$132K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.